5-Bromo-2,4-Dichloropyrimidine CAS 36082-50-5 Purity > 99,0% (GC) Pabrik Panengah Palbociclib
Panganteur Patali Pasokan Kimia Ruifu Palbociclib:
Palbociclib CAS 571190-30-2
5-Bromo-2,4-Dichloropyrimidine CAS 36082-50-5
5-Bromo-2-Chloro-N-Cyclopentylpyrimidin-4-Amine CAS 733039-20-8
tert-Butyl 4-(6-Nitropyridin-3-yl) piperazine-1-Carboxylate CAS 571189-16-7
tert-Butil 4-(6-Amino-3-Pyridyl)piperazin-1-Carboxylate CAS 571188-59-5
6-Bromo-2-Chloro-8-Cyclopentyl-5-Methylpyrido-[2,3-d]pirimidin-7(8H)-hiji CAS 1016636-76-2
2-Chloro-8-Cyclopentyl-5-Metil-8H-Pyrido[2,3-d]pirimidin-7-hiji CAS 1013916-37-4
Ngaran Kimia | 5-Bromo-2,4-Dichloropyrimidine |
Nomer CAS | 36082-50-5 |
Nomer CAT | RF-PI1852 |
Status Saham | Dina Stok, Skala Produksi Nepi ka Ton |
Formula Molekul | C4HBrCl2N2 |
Beurat Molekul | 227.87 |
Titik didih | 128 ℃ / 15 mmHg (lit.) |
Kapadetan | 1,781 g/mL dina 25 ℃ (lit.) |
Indéks réfraktif | n20/D 1.603 (lit.) |
Kalarutan | Leyur dina Métanol |
merek | Kimia Ruifu |
Barang | spésifikasi |
Penampilan | Teu warnaan ka Cairan Konéng Lampu |
Purity / Métode Analisis | > 99,0% (GC) |
Titik Lebur | 29,0 ~ 30,0 ℃ |
Cai (ku Karl Fischer) | <0,50% |
2,4-Dichloropyrimidine | <0,50% (GC) |
Maximun Single Impurity | <0,50% (GC) |
Total Kotoran | <1,00% |
1 H NMR Spéktrum | Konsisten Jeung Struktur |
Standar tés | Standar Perusahaan |
Pamakéan | Panganteur Palbociclib (CAS: 571190-30-2) |
Bungkusan: Botol Fluorinated, 25kg / Drum, atawa nurutkeun sarat customer urang
Kaayaan Panyimpenan:Simpen dina wadah anu disegel dina tempat anu tiis sareng garing;Ngajaga tina cahaya sareng Uap
5-Bromo-2,4-Dichloropyrimidine (CAS: 36082-50-5) tiasa dianggo salaku réagen awal pikeun sintésis modulator alosterik positif pikeun reséptor GABAB (kelas sanyawa sapertos ubar) sareng analog piridinpirimidin.5-Bromo-2,4-Dichloropyrimidine tiasa dianggo salaku perantara Palbociclib (CAS: 571190-30-2).Palbociclib (ogé katelah nomer sanyawa PD-0332991) mangrupikeun ubar ékspérimén pikeun pengobatan kanker payudara anu dikembangkeun ku Pfizer.Palbociclib mangrupikeun inhibitor selektif tina kinase anu gumantung kana cyclin CDK4 sareng CDK6.